CLC Number:
- R473.73
| [1] 李拥军,孙艺红,门剑龙,等.医院内静脉血栓栓塞症防治与管理建议[J].中华医学杂志,2018,98(18):1383-1388. [2] Lyman GH, Culakova E,Poniewierski MS,et al.M Morbidity,Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer[J].Thromb Res,2018,164(suppl1):S112-S118.DOI:10.1016/j.thromres.2018.01.028. [3] Khorana AA, Francis CW, Culakova E, et al.Thromboembolism Is a Leading Cause of Death in Cancer Patients Receiving Outpatient Chemotherapy[J]. J Thromb Haemost,2007,5(3):632-634.DOI:10.1111/j.1538-7836.2007.02374.x. [4] 牛倩,江虹.肿瘤相关静脉血栓的监测进展[J].中华检验医学杂志,2016,39(10):739-742.DOI:10.3760/cma.j.issn.1009-9158.2016.10.003. [5] Khorana AA.Venous Thromboembolism and Prognosis in Cancer[J].Thrombosis Research,2010,125(6):490-493.DOI:10.1016/j.thromres.2009.12.023. [6] Heit JA, Spencer FA,White RH.The Epidemiology of Venous Thromboembolism[J].J Thromb Thrombolysis,2016,41(1):3-14.DOI:10.1007/s11239-015-1311-6. [7] Trinh VQ, Karakiewicz PI, Sammon J, et al.Venous Thromboembolism after Major Cancer Surgery:Temporal Trends and Patterns of Care[J].JAMA surgery,2014,149(1):43-49.DOI:10.1001/jamasurg.2013.3172. [8] Timp JF, Braekkan SK, Versteeg HH, et al.Epidemiology of Cancer-associated Venous Thrombosis[J]. Blood,2013,122(10):1712-1723.DOI:10.1182/BLOOD-2013-04-460121. [9] Posch F, Riedl J,Reitter EM,et al.Hypercoagulahilty,Venous Thromboembolism,and Death in Patients with Cancer. A Multi-state Model[J]. Thromh Haemosl,2016,115(4):817-826.DOI:10.1160/TH15-09-0758. [10] Kuderer NM,Culakova E,Lyman GH,et al.A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality[J]. Oncologist,2016,21(7):861-867.DOI:10.1634/theoncologist.2015-0361. [11] AGREE Enterprise. AGREEⅡinstrument[EB/OL].(2017-12-15)[2018-11-10].https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf. [12] 朱政,胡雁,周英凤,等.推动证据临床转化(五)证据临床转化研究中的文献质量评价[J].2020,35(11):996-1000.DOI:10.16821/j.cnki.hsjx.2020.11.009. [13] Brouwers MC, Kho ME, Browman GP, et al.AGREEⅡ:Advancing Guideline Development,Reporting and Evaluation in Health Care[J].CMAJ,2010,182(18):E839-842.DOI:10.1503/cmaj.090449. [14] Brouwers MC, Kho ME, Browman GP,et al.AGREEⅡ:Advancing Guideline Development,Reporting and Evaluation in Health Care[J].CMAJ,2010,182(18):E839-E842.DOI:10.1503/cmaj.090449. [15] Guyatt G, Oxman AD, Akl EA,et al.GRADE Guidelines:1.Introduction-GRADE Evidence Profiles and Summary of Findings Tables[J].J Clin Epidemiol,2011,64(4):383-394. DOI:10.1016/j.jclinepi.2010.04.026. [16] 陈尹,胡世莲,李幼平,等.全球药物干预治疗单纯性高血压指南的系统评价[J].中国循证医学杂志, 2012, 12(10):1180-1194. [17] 乔舰. 组内相关系数的理论基础及建模应用[J].统计与信息论坛,2016,31(11):44-48. [18] Lyman GH, Carrier M, Ay C, et al.American Society of Hematology 2021 Guidelines for Management of Venous Thromboembolism: Prevention and Treatment in Patients with Cancer[J].Blood Adv, 2021, 5(4):927-974.DOI:10.1182/bloodadvances.2020003442. [19] Kakkos SK, Gohel M, Baekgaard N,et al.European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis[J]. Eur J Vasc Endovasc Surg, 2021, 61(1):9-82.DOI:10.1016/J.EJVS.2020.09.023. [20] Michael BS, Holmstrom B, Dana A,et al.Cancer-Associated Venous Thromboembolic Disease[EB/OL].(2020-04-26)[2020-12-25].https://www.nccn.org/professionals/Physician_gls/pdf/vte.pdf. [21] Rafii H,Frère C,Benzidia I,et al.Management of Cancer-related Thrombosis in the Era of Direct Oral Anticoagulants:A Comprehensive Review of the 2019 ITAC-CME Clinical Practice Guidelines.On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)[J].J Med Vasc,2020,45(1):28-40.DOI:10.1016/j.jdmv.2019.12.004. [22] Venous Thromboembolic Diseases: Diagnosis,Management and Thrombophilia Testing[EB/OL].(2020-03-26)[2020-12-27].http://www.nice.org.uk/guidance/ng158. [23] Farge D,Frere C,Connors JM,et al.2019 International Clinical Practice Guidelines for the Treatment and Prophylaxis of Venous Thromboembolism in Patients with Cancer[J].Lancet Oncol,2019,20(10):e566-e581.DOI:10.1016/S1470-2045(19)30336-5. [24] 中国临床肿瘤学会肿瘤与血栓专家委员会.肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版)[J].中国肿瘤临床, 2019, 46(13):653-660.DOI:10.3969/j.issn.1000-8179.2019.13.765. [25] Mandala M, Falanga A, Roila F. Management of Venous Thromboembolism (VTE) in Cancer Patients: ESMO Clinical Practice Guidelines[J].Ann Oncol,2011,22 (Supplement 6):vi85-vi92.DOI:10.1093/annonc/mdr392. [26] Watson HG, Keeling DM, Laffan M,et al.Guideline on Aspects of Cancer-related Venous Thrombosis[J].Br J Haematology,2015,170(5):640-648.DOI:10.1111/bjh.13556. [27] Zwicker JI, Connolly G,Carrier M,et al.Catheter-associated Deep Vein Thrombosis of the Upper Extremity in Cancer Patients:Guidance from the SSC of the ISTH[J]. J Thromb Haemost,2014,12(5):796-800.DOI:10.1111/jth.12527. [28] Kearon C, Akl EA, Ornelas J,et al.Antithrombotic Therapy for VTE Disease[J].CHEST,2016,149(2):315-352.DOI:10.1016/j.chest.2015.11.026. [29] 《中国血栓性疾病防治指南》专家委员会.中国血栓性疾病防治指南[J].中华医学杂志,2018,98(36):2861-2888.DOI:10.3760/cma.j.issn.0376-2491.2018.36.002. [30] Khorana AA, Otten HM,Zwicker JI,et al,Pabinger I.Prevention of Venous Thromboembolism in Cancer Outpatients: Guidance from the SSC of the ISTH[J].J Thromb Haemost,2014,12(11):1928-1931.DOI:10.1111/jth.12725. [31] Di Nisio M,Carrier M,Lyman GH,et al.Prevention of Venous Thromboembolism in Hospitalized Medical Cancer Patients: Guidance from the SSC of the ISTH[J].J Thromb Haemost,2014,12(10):1746-1749.DOI:10.1111/jth.12683. [32] 王一飞,何少茹.一个新的文献评价系统——GRADE评价系统[J].循证医学,2018,18(5):309-315.DOI:10.12019/j.issn.1671-5144.2018.05.013. |
| [1] | LIU Kai-li, LUO Yan-yan, YAO Gui-ying, ZHU Zhi-ling, GUO Hua, DU Yi-shen, QIN Li-wei, WU Hui-min, LI Jia-bo. Translation of Palliative Care Attitudes Scale and Its Reliability and Validity [J]. Journal of Nursing, 2022, 29(16): 11-16. |
| [2] | OUYANG Die, YANG Jie, YU Xiang-yu, YUAN Xiao-ling. Effects of Endocrine Therapy on Subjective and Objective Cognitive Function in Patients with Breast Cancer: A Systematic Review [J]. Journal of Nursing, 2022, 29(16): 37-42. |
| [3] | SHI Hai-ning, CHEN Ling, ZHOU Li-jing, WANG Li. Construction of Nursing Sensitive Quality Index System for Enhanced Recovery after Surgery of Breast Cancer Patients [J]. Journal of Nursing, 2022, 29(15): 14-18. |
| [4] | . [J]. Journal of Nursing, 2022, 29(15): 54-58. |
| [5] | . [J]. Journal of Nursing, 2022, 29(13): 66-70. |
| [6] | HE Chun-yan, GUO Si-jin, LIN Ya-wei, DU Yan-ling, GAO li, CAO Bao-hua. Characteristics and Predictors of Social Isolation in Female Breast Cancer Patients [J]. Journal of Nursing, 2022, 29(13): 6-11. |
| [7] | . [J]. Journal of Nursing, 2022, 29(13): 32-34. |
| [8] | . [J]. Journal of Nursing, 2022, 29(11): 31-35. |
| [9] | . [J]. Journal of Nursing, 2022, 29(11): 70-72. |
| [10] | . [J]. Journal of Nursing, 2022, 29(11): 59-64. |
| [11] | LIU He, ZHENG Wei, SU Shan-shan, WANG Dan-dan, LIU Meng-li, QU Xiao-feng. Self-compassion and Its Influence Factors of Patients with Recurrent Gastric Cancer: A 205-case Study [J]. Journal of Nursing, 2022, 29(9): 1-4. |
| [12] | ZOU Zi-yu, TANG Hong-mei, WU Li, CHEN Rong-feng, MEI Hua. Scoping Review of Readability Assessment of Breast Cancer-related Health Education Materials [J]. Journal of Nursing, 2022, 29(9): 42-46. |
| [13] | . [J]. Journal of Nursing, 2022, 29(8): 14-18. |
| [14] | LUO Yu-qin, LI Meng-xuan, CHENG Qiu, WANG Ting, ZHENG Jing-yu, FANG Jin-bo, GONG Yu-ping. Case-control Study on Risk Factors of Perianal Infection in Patients with Hematological Malignancy undergoing Chemotherapy [J]. Journal of Nursing, 2022, 29(7): 7-11. |
| [15] | ZHU Fei, LU Qian, QI Juan, BIAN Ying, PANG Li-sha, LIU Chun-lei. Qualitative Research on Fertility Desire of Breast Cancer Patients in Productive Period [J]. Journal of Nursing, 2022, 29(7): 23-26. |
|